Zanzalintinib, CAS [[2367004-54-2]]

Produktübersicht

• Artikelname: Zanzalintinib, CAS [[2367004-54-2]]
• Artikelnummer: MCE-HY-138696
• Hersteller Artikelnummer: HY-138696
• Alternativnummer: MCE-HY-138696-5MG,MCE-HY-138696-10MG,MCE-HY-138696-10MMX1ML,MCE-HY-138696-50MG,MCE-HY-138696-25MG,MCE-HY-138696-100MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: XL092

Produktbeschreibung

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases (RTKs) including MET, VEGFR2, AXL and MER, with IC50s in cell-based assays of 15 nM, 1.6 nM, 3.4 nM, 7.2 nM respectively. Zanzalintinib exhibits anti-tumor activity. Zanzalintinib has the potential for kinase-dependent diseases and conditions research[1][2].

Produkteigenschaften

• Molekulargewicht: 528.53
• Reinheit: 99.91
• CAS Nummer: [2367004-54-2]
• Formel: C29H25FN4O5
• Target-Kategorie: c-Met/HGFR,TAM Receptor,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound